A phase IIb, open-label, randomized controlled dose ranging multi-centre trial to evaluate the safety, tolerability, pharmacokinetics and exposure-response relationship of differen...

por Dierig, A, Hoelscher, M, Schultz, S, Hoffmann, L, Jarchow-MacDonald, A, Svensson, EM, Te Brake, L, Aarnoutse, R, Boeree, M, McHugh, TD, Wildner, LM, Gong, X, Phillips, PPJ, Minja, LT, Ntinginya, N, Mpagama, S, Liyoyo, A, Wallis, RS, Sebe, M, Mhimbira, FA, Mbeya, B, Rassool, M, Geiter, L, Cho, YL, Heinrich, N
Publicado 2023